Australian Trial in Acute Hepatitis C Recall Study
NCT02000063 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 50
Last updated 2014-10-01
Summary
A single long-term follow up assessment of an established multi-centre, prospective longitudinal cohort study of patients for clinical, psychosocial, immunovirological outcomes 4 to 8 years after previous treatment for recently acquired hepatitis C virus infection.
Conditions
- Acute Hepatitis C
Sponsors & Collaborators
-
The University of New South Wales
collaborator OTHER -
Kirby Institute
lead OTHER_GOV
Principal Investigators
-
Gail Matthews, MBChB, MRCP (UK), FRACP, PhD · University of New South Wales, Syndey Australia
Eligibility
- Min Age
- 16 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2012-08-31
- Primary Completion
- 2014-03-31
- Completion
- 2014-03-31
Countries
- Australia
Study Locations
More Related Trials
-
Effects of 48 Weeks Versus 24 Weeks of Therapy With Peg-Intron/Ribavirin in Patients With Chronic Hepatitis C, Genotype 3 (Study P04143)(TERMINATED)
NCT00255034 ·Status: TERMINATED ·Phase: PHASE4
-
Treatment of Recently Acquired Hepatitis C Virus Infection
NCT01336010 ·Status: COMPLETED ·Phase: PHASE4
-
Surveillance and Treatment of Prisoners With Hepatitis C
NCT02064049 ·Status: COMPLETED ·Phase: PHASE4
-
Direct-acting Antiviral Therapy and Reinfection Among PWID With Chronic HCV in Community-based Settings
NCT03343925 ·Status: COMPLETED
-
The National Australian HCV Point-of-Care Testing Program - HCV Antibody Testing Minimal Dataset
NCT05713136 ·Status: RECRUITING
-
The National Australian HCV Point-of-Care Testing Program - Minimal Dataset
NCT05248555 ·Status: RECRUITING
-
The Australian HCV Point-of-Care Testing Program
NCT05042544 ·Status: RECRUITING
-
A Trial of NOV-205 in Hepatitis C Patients Who Failed Standard Therapy
NCT01058512 ·Status: COMPLETED ·Phase: PHASE2
-
A Follow-up Study to Assess Resistance to ABT-072 in HCV-infected Subjects Administered ABT-072 in Prior ABT-072 Studies
NCT00872196 ·Status: COMPLETED ·Phase: PHASE2
-
DAA Based Therapy for Recently Acquired Hepatitis C (DARE-C)
NCT01743521 ·Status: COMPLETED ·Phase: PHASE4
-
A Follow-up Assessment of Resistance to ABT-333 in Hepatitis C Virus (HCV)-Infected Subjects Who Have Received ABT-333 in ABT-333 Studies
NCT00726882 ·Status: COMPLETED ·Phase: PHASE2
-
CPG10101 Combination Therapy For The Treatment Of Hepatitis C In Relapsed Hepatitis C Virus (HCV) Subjects
NCT00142103 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Assess Resistance and Durability of Response to ABT-493 and/or ABT-530
NCT02441283 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Associations, Outcomes and Genomics of GB Virus C, Hepatitis C Virus and Human Immunodeficiency Virus Infection
NCT00164060 ·Status: TERMINATED
-
Long-term Follow-up of HALT-C Sustained Virological Responders
NCT00825877 ·Status: COMPLETED
-
Study of a Novel Therapeutic Vaccine for Hepatitis C Virus
NCT01094873 ·Status: COMPLETED ·Phase: PHASE1
-
A Phase IV Trial of Paritaprevir/Ritonavir, Ombitasvir, Dasabuvir for Chronic Hepatitis C Genotype 1 Virus Infection
NCT02498015 ·Status: COMPLETED ·Phase: PHASE4
-
A Phase II Trial of Sofosbuvir (SOF) and GS-5816 for People With Chronic Hepatitis C Virus Infection and Recent Injection Drug Use
NCT02336139 ·Status: COMPLETED ·Phase: PHASE2
-
A Follow up Study Designed to Obtain Long Term Data on Participants Who Either Achieved a Sustained Virologic Response or Did Not Achieve a Sustained Virologic Response in an AbbVie Sponsored Hepatitis C Study
NCT01773070 ·Status: COMPLETED ·Phase: PHASE3
-
Enhancing Hepatitis C Testing and Treatment Among People Who Inject Drugs Attending Needle and Syringe Programs
NCT04014179 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Immune Response to Hepatitis C Virus
NCT00006301 ·Status: COMPLETED
-
Hepatitis C Lab Testing Comparison Study
NCT06380166 ·Status: TERMINATED
-
Three-year Follow-up Study of Subjects Who Participated in a Previous Asunaprevir (BMS-650032) and/or Daclatasvir (BMS-790052) Chronic Hepatitis C Clinical Trial
NCT01492504 ·Status: COMPLETED
-
Antiviral Activity of AZD7295 in HCV Carriers
NCT00781976 ·Status: COMPLETED ·Phase: PHASE1
-
Trial of Hepatitis C Self-Testing in the Hands of Untrained Lay Users
NCT06369116 ·Status: COMPLETED ·Phase: NA